| __timestamp | Novo Nordisk A/S | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 13762000000 | 1488000000 |
| Thursday, January 1, 2015 | 13608000000 | 1525000000 |
| Friday, January 1, 2016 | 14563000000 | 2111000000 |
| Sunday, January 1, 2017 | 14014000000 | 1848000000 |
| Monday, January 1, 2018 | 14805000000 | 1213000000 |
| Tuesday, January 1, 2019 | 14220000000 | 1010000000 |
| Wednesday, January 1, 2020 | 15462000000 | 997000000 |
| Friday, January 1, 2021 | 17772000000 | 967000000 |
| Saturday, January 1, 2022 | 24047000000 | 838000000 |
| Sunday, January 1, 2023 | 32443000000 | 953000000 |
| Monday, January 1, 2024 | 48062000000 | 998000000 |
Data in motion
In the competitive landscape of the pharmaceutical industry, innovation is key to staying ahead. Novo Nordisk A/S and Teva Pharmaceutical Industries Limited are two giants in this field, each with a distinct approach to research and development (R&D). Over the past decade, Novo Nordisk has consistently outpaced Teva in R&D investment. From 2014 to 2023, Novo Nordisk's R&D expenses surged by approximately 136%, peaking at over 32 billion in 2023. In contrast, Teva's investment in innovation has seen a decline, with a 36% drop over the same period, reaching just under 1 billion in 2023. This stark difference highlights Novo Nordisk's commitment to innovation, potentially driving its future growth and market leadership. As the pharmaceutical industry evolves, the emphasis on R&D will likely continue to shape the competitive dynamics between these two companies.
Research and Development: Comparing Key Metrics for Novo Nordisk A/S and Johnson & Johnson
Novo Nordisk A/S or Teva Pharmaceutical Industries Limited: Who Leads in Yearly Revenue?
Who Prioritizes Innovation? R&D Spending Compared for Novo Nordisk A/S and BioMarin Pharmaceutical Inc.
R&D Insights: How Novo Nordisk A/S and ADMA Biologics, Inc. Allocate Funds
Novo Nordisk A/S or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Novo Nordisk A/S vs Arrowhead Pharmaceuticals, Inc.
R&D Insights: How Novo Nordisk A/S and Taro Pharmaceutical Industries Ltd. Allocate Funds
Teva Pharmaceutical Industries Limited or Intra-Cellular Therapies, Inc.: Who Invests More in Innovation?
Teva Pharmaceutical Industries Limited or Bio-Techne Corporation: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Jazz Pharmaceuticals plc
R&D Spending Showdown: Teva Pharmaceutical Industries Limited vs PTC Therapeutics, Inc.